Is it Pompe Disease? Australian diagnostic considerations

Area of Science:

• Neurology
• Genetics
• Rare Diseases

Background:

• Pompe Disease is a rare neuromuscular disorder with a wide spectrum of clinical presentations, leading to common diagnostic delays.
• Factors contributing to diagnostic delay include rarity, overlapping symptoms with other neuromuscular conditions, and variable diagnostic approaches.
• Existing international guidelines require adaptation for the Australian healthcare context.

Purpose of the Study:

• To develop expert consensus recommendations for the diagnosis and management of Pompe Disease specifically for the Australian setting.
• To address remaining questions and challenges in diagnosing and managing Pompe Disease in Australia.
• To reduce diagnostic delay and improve patient outcomes through tailored guidance.

Main Methods:

• Literature review and synthesis of international guidelines.
• Convening a panel of Australian neurologists and clinical geneticists to review literature and identify clinical questions.
• Developing a framework for guidance, critiqued and refined by a wider expert panel.
• Incorporating clinical expertise to create practical recommendations.

Main Results:

• An expert consensus framework for Pompe Disease diagnosis and management in Australia was developed.
• Recommendations cover diagnosis, classification, therapeutic strategies, multidisciplinary care, and ongoing patient monitoring.
• The framework aims to provide evidence-based insights and practical advice tailored to the Australian context.

Conclusions:

• The developed recommendations provide a tailored approach to Pompe Disease care in Australia.
• Implementation of these guidelines is expected to reduce diagnostic delays.
• Improved diagnosis and management will enhance the care pathway for Australian patients with Pompe Disease.